Numerous male contraceptives have been touted and tested, but generally trials have failed to get off the ground because of seemingly insurmountable side-effects like acne, mood disorders and libido impacts – side-effects women regularly experience on the widely prescribed contraceptive pills.
Solving the dual problem of the overwhelmingly female burden of contraception and the unappealing nature of prescribing side-effect laden medicines for men has thus been a key focus of chemists and pharmacological researchers.
In a new study presented today at the spring meeting of the American Chemical Society (ACS), a team of researchers from the University of Minnesota have obtained promising results in a trial testing a non-hormonal male contraceptive on mice.